AbbVie’s high dividend yield and leadership with Skyrizi and Rinvoq make it a top pick. Learn why ABBV stock is a strong buy ...

Halozyme Therapeutics (HALO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

Analyst Brian Essex from J.P. Morgan reiterated a Buy rating on CrowdStrike Holdings (CRWD – Research Report) and increased the price target to ...

Baidu's Q3 earnings disappoint, but long-term prospects shine bright with strong AI and autonomous driving advancements. See ...

List today:StoneX Group Inc. SNEX: This global financial services network provider has seen the Zacks Consensus Estimate for ...

Americans looking to purchase a home in the next few years will have a tough pill to swallow. After hitting two-decade highs ...

The Acer Swift Go 14 AI is the lower-cost version of Acer's mainstream Swift 14 AI thin-and-light laptop, but the two laptops ...

Overall, Elastic’s strong execution and positioning for the GenAI opportunity support the Buy rating. In another report released today, Piper Sandler also maintained a Buy rating on the stock with a ...

Nvidia reported earnings that saw revenue and EPS come in stronger than Wall Street forecasts, though the stock fell 2% amid ...

The New York Rangers' strong start to 2024-25 has belied serious structural issues - ones that threaten to derail their ...

Snowflake stock is surging Thursday after cloud company beat expectations for its third quarter and raised its full-year ...

Applied Materials' growth is gradually picking up Applied Materials' fiscal Q4 revenue jumped 5% year over year to a record ...